|
|
||||||||
From the Department of Neurology (Drs. DeCarli, Mungas, Reed, and Jagust), Center for Neuroscience (Drs. DeCarli and Jagust), Division of Biostatistics (Dr. Harvey), Department of Epidemiology and Preventive Medicine, and Division of Neuroradiology (Dr. Weiner), Department of Radiology, University of California at San Francisco, and Department of Neurology (Dr. Chui), University of Southern California, Los Angeles.
Address correspondence and reprint requests to Dr. C. DeCarli, Department of Neurology, 4860 Y St., Suite 3700, Sacramento, CA 95817; e-mail: cdecarli{at}ucdavis.edu
Background: Mild cognitive impairment (MCI) is widely viewed as the transition phase between normal aging and Alzheimer disease (AD). Given that MCI can also result from cerebrovascular disease (CVD), the authors used clinical, MRI, and cognitive measures of AD and CVD to test the hypothesis that CVD increases the likelihood of progression from MCI to dementia within 3 years.
Objective: To examine the impact of CVD on progression of MCI to dementia.
Methods: Fifty-two consecutive patients with MCI (71% men) including many with symptomatic CVD were longitudinally evaluated for 3.1 ± 1.3 years. MCI was defined as a Clinical Dementia Rating Scale (CDR) score of 0.5. Dementia was defined as progression to a CDR score of
1.0.
Results: Forty-four percent of the MCI patients had MRI infarcts, 50% of which were symptomatic. Thirty-three percent of patients progressed to dementia, and 37.8% of these had MRI infarcts. Clinically probable or possible AD was diagnosed in approximately 82% of converters. Of the clinical and MRI measures, only hippocampal volume was associated with increased risk to progression (hazard ratio [HR] = 0.31 [95% CI 0.1 to 0.92], p = 0.03). When neuropsychological measures were included in the analysis, memory (HR = 0.90 [95% CI 0.84 to 0.96], p = 0.002) and executive function (HR = 0.96 [95% CI 0.92 to 1.0], p = 0.045) were associated with increased risk of dementia progression, whereas APOE genotype, cerebrovascular risk factors, clinical stroke, presence or absence of lacunes, and extent of white matter hyperintensities did not predict progression.
Conclusion: Within a heterogenous group of MCI patients, including many with clinically significant CVD, baseline memory and executive performance significantly predicted likelihood to develop dementia.
Received August 25, 2003. Accepted in final form March 19, 2004.
This article has been cited by other articles:
![]() |
P. H. Lu, S. D. Edland, E. Teng, K. Tingus, R. C. Petersen, J. L. Cummings, and On behalf of The Alzheimer's Disease Cooperative S Donepezil delays progression to AD in MCI subjects with depressive symptoms Neurology, June 16, 2009; 72(24): 2115 - 2121. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kantarci, S. D. Weigand, S. A. Przybelski, M. M. Shiung, J. L. Whitwell, S. Negash, D. S. Knopman, B. F. Boeve, P. C. O'Brien, R. C. Petersen, et al. Risk of dementia in MCI: Combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS Neurology, April 28, 2009; 72(17): 1519 - 1525. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Staekenborg, E. L.G.E. Koedam, W. J.P. Henneman, P. Stokman, F. Barkhof, P. Scheltens, and W. M. van der Flier Progression of Mild Cognitive Impairment to Dementia: Contribution of Cerebrovascular Disease Compared With Medial Temporal Lobe Atrophy Stroke, April 1, 2009; 40(4): 1269 - 1274. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kantarci, R. C. Petersen, S. A. Przybelski, S. D. Weigand, M. M. Shiung, J. L. Whitwell, S. Negash, R. J. Ivnik, B. F. Boeve, D. S. Knopman, et al. Hippocampal Volumes, Proton Magnetic Resonance Spectroscopy Metabolites, and Cerebrovascular Disease in Mild Cognitive Impairment Subtypes Arch Neurol, December 1, 2008; 65(12): 1621 - 1628. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bombois, S. Debette, A. Bruandet, X. Delbeuck, C. Delmaire, D. Leys, and F. Pasquier Vascular Subcortical Hyperintensities Predict Conversion to Vascular and Mixed Dementia in MCI Patients Stroke, July 1, 2008; 39(7): 2046 - 2051. [Abstract] [Full Text] [PDF] |
||||
![]() |
S L Miller, E Fenstermacher, J Bates, D Blacker, R A Sperling, and B C Dickerson Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive decline J. Neurol. Neurosurg. Psychiatry, June 1, 2008; 79(6): 630 - 635. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Jack Jr, S. D. Weigand, M. M. Shiung, S. A. Przybelski, P. C. O'Brien, J. L. Gunter, D. S. Knopman, B. F. Boeve, G. E. Smith, and R. C. Petersen Atrophy rates accelerate in amnestic mild cognitive impairment Neurology, May 6, 2008; 70(19_Part_2): 1740 - 1752. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Smith, S. Egorova, D. Blacker, R. J. Killiany, A. Muzikansky, B. C. Dickerson, R. E. Tanzi, M. S. Albert, S. M. Greenberg, and C. R. G. Guttmann Magnetic Resonance Imaging White Matter Hyperintensities and Brain Volume in the Prediction of Mild Cognitive Impairment and Dementia Arch Neurol, January 1, 2008; 65(1): 94 - 100. [Abstract] [Full Text] [PDF] |
||||
![]() |
S MILLS, J CAIN, N PURANDARE, and A JACKSON Biomarkers of cerebrovascular disease in dementia Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S128 - S145. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Debette, S. Bombois, A. Bruandet, X. Delbeuck, S. Lepoittevin, C. Delmaire, D. Leys, and F. Pasquier Subcortical Hyperintensities Are Associated With Cognitive Decline in Patients With Mild Cognitive Impairment Stroke, November 1, 2007; 38(11): 2924 - 2930. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. van de Pol, E. S. C. Korf, W. M. van der Flier, H. R. Brashear, N. C. Fox, F. Barkhof, and P. Scheltens Magnetic Resonance Imaging Predictors of Cognition in Mild Cognitive Impairment Arch Neurol, July 1, 2007; 64(7): 1023 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Whitwell, S. A. Przybelski, S. D. Weigand, D. S. Knopman, B. F. Boeve, R. C. Petersen, and C. R. Jack Jr 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease Brain, July 1, 2007; 130(7): 1777 - 1786. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-C. Liu, P.-N. Wang, H.-C. Wang, K.-N. Lin, C.-J. Hong, C.-Y. Liu, and P.-H. Tsai Conversion to Dementia From Questionable Dementia in an Ethnic Chinese Population J Geriatr Psychiatry Neurol, June 1, 2007; 20(2): 76 - 83. [Abstract] [PDF] |
||||
![]() |
F. Panza, C. Capurso, A. D'Introno, A. M. Colacicco, M. Chirico, A. Capurso, V. Solfrizzi, and R. O'Brien EFFECT OF A CLINICAL STROKE ON THE RISK OF DEMENTIA IN A PROSPECTIVE COHORT Neurology, May 15, 2007; 68(20): 1748 - 1749. [Full Text] [PDF] |
||||
![]() |
D. P. Devanand, G. Pradhaban, X. Liu, A. Khandji, S. De Santi, S. Segal, H. Rusinek, G. H. Pelton, L. S. Honig, R. Mayeux, et al. Hippocampal and entorhinal atrophy in mild cognitive impairment: Prediction of Alzheimer disease Neurology, March 13, 2007; 68(11): 828 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. T. Aggarwal, R. S. Wilson, T. L. Beck, J. L. Bienias, and D. A. Bennett Motor Dysfunction in Mild Cognitive Impairment and the Risk of Incident Alzheimer Disease Arch Neurol, December 1, 2006; 63(12): 1763 - 1769. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gamaldo, A. Moghekar, S. Kilada, S. M. Resnick, A. B. Zonderman, and R. O'Brien Effect of a clinical stroke on the risk of dementia in a prospective cohort Neurology, October 24, 2006; 67(8): 1363 - 1369. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sunderland, H. Hampel, M. Takeda, K. T. Putnam, and R. M. Cohen Biomarkers in the Diagnosis of Alzheimer's Disease: Are We Ready? J Geriatr Psychiatry Neurol, September 1, 2006; 19(3): 172 - 179. [Abstract] [PDF] |
||||
![]() |
F. Panza, C. Capurso, and V. Solfrizzi Stroke and memory decline: a question of degenerative or vascular origin. Arch Neurol, September 1, 2006; 63(9): 1347 - 1348. [Full Text] [PDF] |
||||
![]() |
M. H. Tabert, J. J. Manly, X. Liu, G. H. Pelton, S. Rosenblum, M. Jacobs, D. Zamora, M. Goodkind, K. Bell, Y. Stern, et al. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry, August 1, 2006; 63(8): 916 - 924. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cordonnier, W. M. van der Flier, J. D. Sluimer, D. Leys, F. Barkhof, and P. Scheltens Prevalence and severity of microbleeds in a memory clinic setting Neurology, May 9, 2006; 66(9): 1356 - 1360. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Reitz, J. A. Luchsinger, M.-X. Tang, J. Manly, and R. Mayeux Stroke and memory performance in elderly persons without dementia. Arch Neurol, April 1, 2006; 63(4): 571 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mungas, D. Harvey, B. R. Reed, W. J. Jagust, C. DeCarli, L. Beckett, W. J. Mack, J. H. Kramer, M. W. Weiner, N. Schuff, et al. Longitudinal volumetric MRI change and rate of cognitive decline Neurology, August 23, 2005; 65(4): 565 - 571. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Boxer, J. H. Kramer, K. Johnston, J. Goldman, R. Finley, and B. L. Miller Executive dysfunction in hyperhomocystinemia responds to homocysteine-lowering treatment Neurology, April 26, 2005; 64(8): 1431 - 1434. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Koppel, C. DeCarli, D. Mungas, D. Harvey, B. Reed, M. Wiener, H. Chui, and W. Jagust Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia Neurology, February 22, 2005; 64(4): 766 - 766. [Full Text] [PDF] |
||||
Read all Correspondence
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |